South Carolina reported 510 new confirmed cases of the coronavirus and 14 new deaths today.
Here's the latest on the pandemic in South Carolina.
The Coastal Carolina baseball team has been forced to pause all activities, including postponing its next five games, due to COVID-19 protocols in its program on April 1.
3:30 p.m. — The Coastal Carolina baseball team has paused all activities, including games and practices, for seven days due to COVID-19 protocols in the Chanticleers program on April 1. Read more.
The S.C. Department of Health and Environmental Control said more than 2 million COVID-19 vaccinations have been given in the Palmetto State.
2:15 p.m. — More than 2 million COVID-19 vaccine doses have been given in South Carolina. The state reached the milestone this week as all residents age 16 and older became eligible for the shot. Read more.
As most South Carolina residents become eligible, coronavirus vaccinations for one of the state's most vulnerable populations are starting to ramp up.
1 p.m. — As most South Carolina residents become eligible, coronavirus vaccinations for one of the state’s most vulnerable populations are starting to ramp up.
People incarcerated in South Carolina’s prisons and jails began receiving the vaccine in March and, with eligibility and vaccine allocations expanding, administrators are gearing up to fully vaccinate their populations. Read more.
1 p.m. — New small business loans aimed at combating the financial hardships of the COVID-19 pandemic found their first recipients this week.
The Turning Page Bookshop and Acute Heating & Cooling were the first small business owners to take advantage of “Kickstart the Creek,” a loan program and partnership between the city of Goose Creek and Charleston LDC that will serve as a direct line of help for businesses affected by the pandemic. Read more.
Emergent BioSolutions, a little-known company vital to the vaccine supply chain, was a key to Johnson & Johnson's plan to deliver 100 million doses of its vaccine to the United States by the end of May. But the Food and Drug Administration repeatedly has cited Emergent for problems such as poorly trained employees, cracked vials and problems managing mold and other contamination around one of its facilities, according to records obtained by The Associated Press through the Freedom of Information Act. The records cover inspections at Emergent facilities since 2017.
12:25 p.m. — The company at the center of quality problems that led Johnson & Johnson to discard 15 million doses of its coronavirus vaccine has a string of citations from U.S. health officials for quality-control problems. Read more.
A batch of Johnson & Johnson's COVID-19 vaccine failed quality standards and can't be used, the drug giant said late Wednesday.
Wednesday, 8:12 p.m. — A batch of Johnson & Johnson’s COVID-19 vaccine failed quality standards and can’t be used, the drug giant said Wednesday. The drugmaker didn’t say how many doses were lost, and it wasn’t clear how the problem would impact future deliveries.
A vaccine ingredient made by Emergent BioSolutions — one of about 10 companies that Johnson & Johnson is using to speed up manufacturing of its recently approved vaccine — did not meet quality standards, J&J said. Read more.